Snoring is recognised as a key indicator of Obstructive Sleep Apnoea (OSA). The deprivation of oxygen, and lack of deep sleep, is increasingly identified as a key risk factor associated with stroke, diabetes and cardiovascular disease. It is estimated that 2 - 4% of middle-aged adults suffer from the condition, with more than 80% of sufferers currently undiagnosed.

Existing home‐based diagnostic technologies for OSA fail to deliver the necessary feature set to facilitate people to take control over the management of their own health and test themselves for this potentially life threatening condition. The UQ-devleoped SnoreSounds represents an innovative technology for in‐home, non‐contact and automated OSA screening using advanced analysis of the sound of the patient’s snore. 

• Investors

www.snoresounds.com.au

Return to the Research Innovation Portfolio